Egf Theramed Health Stock Performance
| EVAHF Stock | USD 0.21 0.02 10.53% |
EGF Theramed holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 12.47, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, EGF Theramed will likely underperform. Use EGF Theramed information ratio, skewness, price action indicator, as well as the relationship between the treynor ratio and rate of daily change , to analyze future returns on EGF Theramed.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in EGF Theramed Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady technical indicators, EGF Theramed reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 702.4 K | |
| Free Cash Flow | -993.4 K |
EGF |
EGF Theramed Relative Risk vs. Return Landscape
If you would invest 9.50 in EGF Theramed Health on August 26, 2024 and sell it today you would earn a total of 11.50 from holding EGF Theramed Health or generate 121.05% return on investment over 90 days. EGF Theramed Health is currently producing 10.9177% returns and takes up 80.7269% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than EGF, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
EGF Theramed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EGF Theramed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as EGF Theramed Health, and traders can use it to determine the average amount a EGF Theramed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1352
| Best Portfolio | Best Equity | EVAHF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 80.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average EGF Theramed is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EGF Theramed by adding it to a well-diversified portfolio.
EGF Theramed Fundamentals Growth
EGF Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of EGF Theramed, and EGF Theramed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EGF Pink Sheet performance.
| Return On Equity | -2.11 | |||
| Return On Asset | -0.72 | |||
| Current Valuation | 4.72 M | |||
| Shares Outstanding | 10.49 M | |||
| Price To Book | 42.04 X | |||
| EBITDA | (1.35 M) | |||
| Cash And Equivalents | 51.98 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 1.23 M | |||
| Debt To Equity | 6.69 % | |||
| Book Value Per Share | (0.08) X | |||
| Cash Flow From Operations | (993.42 K) | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 178.67 K | |||
About EGF Theramed Performance
By analyzing EGF Theramed's fundamental ratios, stakeholders can gain valuable insights into EGF Theramed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if EGF Theramed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EGF Theramed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. Egf Theramed operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about EGF Theramed Health performance evaluation
Checking the ongoing alerts about EGF Theramed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for EGF Theramed Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EGF Theramed Health is way too risky over 90 days horizon | |
| EGF Theramed Health has some characteristics of a very speculative penny stock | |
| EGF Theramed Health appears to be risky and price may revert if volatility continues | |
| EGF Theramed Health has high likelihood to experience some financial distress in the next 2 years | |
| EGF Theramed Health has accumulated 1.23 M in total debt with debt to equity ratio (D/E) of 6.69, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. EGF Theramed Health has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist EGF Theramed until it has trouble settling it off, either with new capital or with free cash flow. So, EGF Theramed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EGF Theramed Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EGF to invest in growth at high rates of return. When we think about EGF Theramed's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.35 M) with loss before overhead, payroll, taxes, and interest of (105.22 K). | |
| EGF Theramed Health has accumulated about 51.98 K in cash with (993.42 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. |
- Analyzing EGF Theramed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EGF Theramed's stock is overvalued or undervalued compared to its peers.
- Examining EGF Theramed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EGF Theramed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EGF Theramed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EGF Theramed's pink sheet. These opinions can provide insight into EGF Theramed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for EGF Pink Sheet analysis
When running EGF Theramed's price analysis, check to measure EGF Theramed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EGF Theramed is operating at the current time. Most of EGF Theramed's value examination focuses on studying past and present price action to predict the probability of EGF Theramed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EGF Theramed's price. Additionally, you may evaluate how the addition of EGF Theramed to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |